Allozymes, Pte. Ltd. is a leading deep technology company that applies its proprietary microfluidics technology to develop custom-designed enzymes for cleaner and sustainable manufacturing of complex natural products. Allozymes’ interdisciplinary innovation enables 10x faster enzyme engineering with 200X higher chance of success compared to robotics which enables breakthrough development in a wide range of industries.
Location: Singapore
Employees: 11-50
Total raised: $20M
Founded date: 2020
Investors 3
| Date | Name | Website |
| 01.03.2022 | Plug and P... | plugandpla... |
| - | Thia Ventu... | thiaventur... |
| - | Transpose ... | transposep... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 16.05.2024 | Series A | $15M | - |
| 07.07.2021 | Seed | $5M | - |
Mentions in press and media 19
| Date | Title | Description |
| 31.03.2025 | Allozymes and Bonumose Collaborate to Accelerate Enzyme Innovations for Beneficial Food & Supplement Ingredients | SINGAPORE, March 31, 2025 /PRNewswire/ -- Allozymes, a leader in protein engineering, and Bonumose, a leader in innovative enzyme combinations enabling the production of high-volume, healthy, naturally occurring monosaccharides from commodi... |
| 19.08.2024 | Allozymes and Adisseo Partner on Next-Gen Animal Feed Production Using Rapid Microfluidics Technology | SINGAPORE, Aug. 19, 2024 /PRNewswire/ -- Allozymes, a leading innovator in enzyme discovery and engineering, today announces a strategic partnership with Adisseo, one of the world's leading animal nutrition companies, to develop groundbreak... |
| 21.05.2024 | ScaleUp Bio Obtains Food Manufacturing Licence for Precision Fermentation in Singapore | 4 Mins Read The Singapore Food Agency has granted a food production licence to ScaleUp Bio’s commercial-scale facility for submerged- and precision-fermented ingredients. ScaleUp Bio has received a food manufacturing licence from Singapore’... |
| 16.05.2024 | Allozymes raised $15 M Series A funding from Seventure Partners, Xora Innovation | The $15 million Series A funding round led by French investment firm Seventure Partners and Singaporean startup Xora Innovation was closed on Monday, according to Allozymes, a pioneer in enzyme engineering and discovery based in Singapore. ... |
| 15.05.2024 | Allozymes: Pioneering Enzyme Innovation to Transform Industries Worldwide | Allozymes, a dynamic biotechnology startup based in Singapore, recently announced a significant milestone with the successful closure of a $15 million Series A funding round. This substantial investment, led by esteemed investors Seventure ... |
| 14.05.2024 | Allozymes Raises $15M in Series A Funding | Allozymes, a Singapore-based innovator in enzyme discovery and engineering, raised $15M in Series A funding. The round was led by Seventure Partners of France and Xora Innovation of Singapore. The company intends to use the funds to acceler... |
| 14.05.2024 | Allozymes Raises $15 Million in Series A Funding, Poised to Revolutionize Industries with Enzymatic Solutions | SINGAPORE, May 14, 2024 /PRNewswire/ -- Allozymes, a leading innovator in enzyme discovery and engineering, today announced the closing of a $15 million Series A funding round led by Seventure Partners of France and Xora Innovation of Singa... |
| 14.05.2024 | Biotech startup Allozymes closes $15m Series A co-led by Seventure, Xora Innovation | Singapore-headquartered biotech startup Allozymes, which specialises in enzyme discovery and engineering, on Tuesday announced the close of a $15-million Series A round co-led by Seventure Partners and Xora Innovation. |
| 13.05.2024 | Temasek-backed Allozymes secures $15m for European expansion | News Lokesh Choudhary · 12h ago · 2 min readTemasek-backed Allozymes secures $15m for European expansion Allozymes founders Peyman Salehian (left) and Akbar Vahidi / Photo credit: Allozymes Allozymes, a Singapore-based synthetic biotech sta... |
| 03.05.2024 | Allozymes puts its accelerated enzymatics to work on a data and AI play, raising $15M | Allozymes’ ingenious method of quickly testing millions of bio-based chemical reactions is proving to be not just a useful service, but the basis of a unique and valuable dataset. And where there’s a dataset, there’s AI — and where there’s ... |
Show more